Lazard Asset Management’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.62M Buy
182,931
+138,636
+313% +$2.3M ﹤0.01% 779
2025
Q4
$781K Buy
44,295
+3,757
+9% +$62.1K ﹤0.01% 1224
2025
Q3
$638K Buy
40,538
+5,564
+16% +$78.1K ﹤0.01% 1274
2025
Q2
$388K Buy
34,974
+24,395
+231% +$286K ﹤0.01% 1565
2025
Q1
$122K Buy
10,579
+3,955
+60% +$50.9K ﹤0.01% 1758
2024
Q4
$89K Sell
6,624
-2,380
-26% -$34.5K ﹤0.01% 1836
2024
Q3
$149K Buy
9,004
+1,962
+28% +$28.7K ﹤0.01% 1676
2024
Q2
$82K Buy
7,042
+3,190
+83% +$36.4K ﹤0.01% 1810
2024
Q1
$46K Sell
3,852
-2,784
-42% -$41.4K ﹤0.01% 1734
2023
Q4
$110K Sell
6,636
-4,344
-40% -$61.5K ﹤0.01% 1621
2023
Q3
$163K Buy
10,980
+2,083
+23% +$35.1K ﹤0.01% 1457
2023
Q2
$167K Sell
8,897
-1,929
-18% -$30.7K ﹤0.01% 1403
2023
Q1
$193K Buy
10,826
+918
+9% +$15.3K ﹤0.01% 1320
2022
Q4
$82K Buy
9,908
+1,217
+14% +$9.08K ﹤0.01% 1603
2022
Q3
$59K Sell
8,691
-4,660,379
-100% -$77.5M ﹤0.01% 1728
2022
Q2
$91.5M Sell
4,669,070
-687,312
-13% -$14.4M 0.12% 152
2022
Q1
$116M Sell
5,356,382
-343,159
-6% -$7.28M 0.13% 145
2021
Q4
$134M Sell
5,699,541
-347,774
-6% -$8.32M 0.14% 129
2021
Q3
$158M Buy
6,047,315
+1,336
+0% +$32.3K 0.18% 101
2021
Q2
$146M Buy
6,045,979
+273,239
+5% +$6.72M 0.16% 108
2021
Q1
$144M Buy
5,772,740
+2,120,909
+58% +$56.1M 0.17% 108
2020
Q4
$100M Buy
+3,651,831
New +$98M 0.13% 143

Other funds holding SHC

Lazard Asset Management's SHC Position: Q1 2026 in Review

Lazard Asset Management increased its Sotera Health (SHC) stake by 313% in Q1 2026, buying an estimated $2.3M and bringing the position to 182,931 shares worth $2.62M. The position accounts for ﹤0.01% of the portfolio, ranked #779.

Lazard Asset Management first reported a position in SHC in Q4 2020 and has held it in 22 quarters since. The position peaked at $158M in Q3 2021. 296 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • Lazard Asset Management held 182,931 shares of Sotera Health worth $2.62M as of Q1 2026.
  • Lazard Asset Management bought 138,636 Sotera Health shares in Q1 2026, an estimated $2.3M.
  • Sotera Health made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #779 holding.
  • Lazard Asset Management first reported a position in Sotera Health in Q4 2020 and has held it in 22 quarters since.
  • Lazard Asset Management's Sotera Health position peaked at $158M in Q3 2021.
  • 296 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.